UNSPSC 42294303: Minimally invasive breast biopsy needle guides

In this classification, this commodity indicates a product used as a minimally invasive breast biopsy needle guides during a surgical procedure in a medical setting. US FDA regulates Minimally invasive breast biopsy needle guides under 21 CFR 876.1075 and under FDA product code FCG. Most nations, for tariff and trade purposes, schedule these products under HS 901890.

UNSPSC 42294303 Minimally invasive breast biopsy needle guides (Commodity) shows minimal relevant recent activity in state and local procurement. The recent-opportunities block contains five postings, none of which align with the code's nominal scope of breast biopsy equipment or supplies. The opportunities span laser equipment and OR technical support (San Mateo County Medical Center), surgical power instruments (San Mateo County Medical Center), outpatient building furniture (State of California), law enforcement equipment (Sourcewell cooperative procurement), and phlebotomy services for DUI enforcement (Nevada State Police) — none related to diagnostic imaging, biopsy equipment, or breast health procurement.

The disconnect between the code name and the actual work posted under it suggests either miscategorization in the source data or that state and local jurisdictions are not currently soliciting minimally invasive breast biopsy needle guides through this UNSPSC code. The issuing bodies in the recent-opportunities block include a county health system (San Mateo), a state capital-projects procurement (California), a multi-state cooperative purchasing vehicle (Sourcewell), and a state law enforcement agency (Nevada), with no evident focus on medical device procurement or breast imaging supplies. Without substantive recent opportunities matching the code's definition, this code does not present a reliable signal of active demand or buyer concentration at present.